Warwickshire, United Kingdom

Daniel Tyce

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Sanofi-A Ventis Deutschland Gmbh. Active years: 2016.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniel Tyce

Introduction

Daniel Tyce is an accomplished inventor based in Warwickshire, GB. He is known for his contributions to the field of medical devices, particularly in the development of injection technology. His innovative approach has led to the creation of a unique product that enhances the user experience in administering medication.

Latest Patents

Daniel Tyce holds a patent for a "Pen-type injector with ergonomic button arrangement." This hand-held injection device is designed for the injection of a medicament from a first medicament cartridge. The ergonomic button arrangement allows for easier handling and improved usability, making it a significant advancement in the field of medical devices.

Career Highlights

Daniel is currently employed at Sanofi-Aventis Deutschland GmbH, where he continues to work on innovative solutions in the healthcare sector. His dedication to improving medical technology has made a positive impact on patient care and medication administration.

Collaborations

Throughout his career, Daniel has collaborated with talented professionals, including Irina Lanin and Christopher Nigel Langley. These partnerships have fostered a creative environment that encourages the development of groundbreaking medical devices.

Conclusion

Daniel Tyce's contributions to the field of medical devices exemplify the importance of innovation in healthcare. His work not only enhances the user experience but also plays a crucial role in improving patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…